Talk:HLA-G

Suggestion: to add a section on HLA-G as a therapeutic target
disclaimer:

I'm new here, so I didn't want to edit the main page directly. I also hold a patent on HLA-G-based therapeutics (for use in autoimmune diseases), but are not associated with the companies/projects that are further developed and which I would thus suggest to add here (use as target in cancer therapy)

TTX-080 is a therapeutic antibody developed by Tizona and Gilead for cancer therapy which blocks the interaction of HLA-G and immunossuppressive receptors https://jitc.bmj.com/content/8/Suppl_3/A419.2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278316/

Invectys is developing CAR-T cells that target HLA-G https://jitc.bmj.com/content/jitc/9/3/e001998.full.pdf?with-ds=yes  — Preceding unsigned comment added by Vbruttel (talk • contribs) 20:27, 29 September 2023 (UTC)

Untitled

 * I'm making the following bibliography